Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.

Krishnan Natesan S, Wu W, Cutright JL, Chandrasekar PH.

Diagn Microbiol Infect Dis. 2012 Nov;74(3):272-7. doi: 10.1016/j.diagmicrobio.2012.06.030. Epub 2012 Aug 14.

PMID:
22897872
2.

In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.

Krishnan-Natesan S, Wu W, Chandrasekar PH.

Diagn Microbiol Infect Dis. 2012 Jun;73(2):135-7. doi: 10.1016/j.diagmicrobio.2012.02.003.

PMID:
22608136
3.

Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.

Krishnan-Natesan S, Manavathu EK, Cutright JL, Chandrasekar PH.

Int J Antimicrob Agents. 2010 Jul;36(1):33-6. doi: 10.1016/j.ijantimicag.2010.02.020. Epub 2010 Apr 18.

PMID:
20400270
4.

Terbinafine: a pharmacological and clinical review.

Krishnan-Natesan S.

Expert Opin Pharmacother. 2009 Nov;10(16):2723-33. doi: 10.1517/14656560903307462. Review.

PMID:
19874252
5.

A comparison of the fungicidal activity of amphotericin B and posaconazole against Zygomycetes in vitro.

Krishnan-Natesan S, Manavathu EK, Alangaden GJ, Chandrasekar PH.

Diagn Microbiol Infect Dis. 2009 Apr;63(4):361-4. doi: 10.1016/j.diagmicrobio.2008.12.013.

PMID:
19302924
6.

Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.

Krishnan-Natesan S, Chandrasekar PH, Manavathu EK, Revankar SG.

Diagn Microbiol Infect Dis. 2008 Dec;62(4):443-6. doi: 10.1016/j.diagmicrobio.2008.08.003. Epub 2008 Oct 7.

PMID:
18842377
7.

Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.

Krishnan-Natesan S, Chandrasekar PH, Alangaden GJ, Manavathu EK.

Int J Antimicrob Agents. 2008 Dec;32(6):519-24. doi: 10.1016/j.ijantimicag.2008.06.018. Epub 2008 Sep 4.

PMID:
18775650
8.

Current and future therapeutic options in the management of invasive aspergillosis.

Krishnan-Natesan S, Chandrasekar PH.

Drugs. 2008;68(3):265-82. Review.

PMID:
18257606

Supplemental Content

Loading ...
Support Center